Product image of Meropenem Steriscience (Meropenem Anhydrous) supplied by GNH India

Meropenem Steriscience

Active Ingredient:
Meropenem Anhydrous
Origin:
EU

Meropenem Steriscience (Meropenem Anhydrous)

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable for intravenous use. It treats severe bacterial infections such as intra‑abdominal, urinary tract, pulmonary, bloodstream and central nervous system infections in hospitalized patients.

GNH India supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare institutions. Meropenem Steriscience is manufactured under EU GMP guidelines, ensuring batch consistency and purity for critical care use.

Manufacturer / TM Owner

Steriscience B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious infections caused by Gram‑negative and Gram‑positive bacteria.

  • Complicated intra‑abdominal infections: provides rapid bacterial clearance in polymicrobial abdominal sepsis.
  • Complicated urinary tract infections: eradicates resistant uropathogens, aiding resolution of pyelonephritis.
  • Hospital‑acquired pneumonia: penetrates lung tissue to treat multidrug‑resistant pneumonia.
  • Septicemia: achieves high plasma concentrations to control bloodstream infection.
  • Meningitis: crosses the blood‑brain barrier to treat bacterial meningitis.

How It Works

  • Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. The drug is resistant to most β‑lactamases, allowing activity against a wide range of Gram‑negative, Gram‑positive and anaerobic organisms.

Side Effects

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: may be watery and self‑limiting.
  • Rash: erythematous skin eruption.
  • Headache: transient cranial discomfort.
  • Injection site reactions: pain or erythema at the infusion site.
  • Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

  • Seizures: especially in patients with renal impairment or CNS disease.
  • Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.
  • Anaphylaxis: acute hypersensitivity reaction requiring emergency care.
  • Severe neutropenia: marked reduction in white blood cells.
  • Renal toxicity: acute kidney injury in susceptible individuals.
  • Hepatic failure: rare but potentially life‑threatening liver dysfunction.

Precautions & Warnings

Meropenem should be used with caution in specific clinical situations.

  • Renal function: adjust dose in patients with impaired clearance.
  • Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams.
  • Pregnancy: prescribe only when benefits outweigh potential risks.
  • Concomitant valproic acid: monitor for reduced antiepileptic effect.
  • Superinfection: watch for secondary fungal or bacterial infections.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Meropenem may interact with other medicines; monitoring is advised.

Major Interactions (Avoid)

  • Valproic acid: may reduce antiepileptic efficacy, risking seizure breakthrough.
  • Aminoglycosides: additive nephrotoxicity when combined.
  • Other nephrotoxic agents: increased risk of renal impairment.

Moderate Interactions (Monitor Closely)

  • Warfarin: may potentiate anticoagulant effect, requiring INR monitoring.
  • Loop diuretics: may affect renal clearance of meropenem.
  • Probenecid: can increase meropenem plasma concentrations, necessitating dose review.

Frequently Asked Questions

Meropenem Steriscience is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, septicemia and bacterial meningitis. It is reserved for cases where broad‑spectrum coverage against resistant Gram‑negative and Gram‑positive organisms is required.

Meropenem inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, causing structural weakness and ultimately bacterial lysis. Its resistance to most β‑lactamases expands its activity to many multidrug‑resistant pathogens.

The dosing regimen for Meropenem Steriscience is determined by the prescribing clinician based on infection type, severity, patient weight, renal function and local susceptibility patterns. No fixed dose is provided here; the prescriber tailors therapy to each individual case.

Safety data for Meropenem in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a specialist obstetrician is recommended before initiating therapy.

To place an order, submit an enquiry on the Meropenem Steriscience product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Meropenem offers a broad spectrum similar to other carbapenems such as imipenem‑cilastatin and ertapenem, but it has a slightly lower propensity for inducing seizures and provides reliable activity against Pseudomonas aeruginosa. Choice among carbapenems depends on pathogen susceptibility, site of infection, renal function and safety considerations.

Meropenem Steriscience must be stored refrigerated at 2‑8 °C, protected from light, and should not be frozen or shaken. Once reconstituted, the solution should be used within the time frame specified in the product labeling and kept under the same temperature conditions until administration.

The product is supplied as an injectable solution for intravenous infusion. It is administered by a healthcare professional through a peripheral or central line, typically over 15‑30 minutes, depending on the prescribed dose and clinical protocol.

The most critical adverse events to monitor are seizures (especially in patients with renal impairment or CNS disease), severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare cases of hepatic or renal failure. Prompt medical evaluation is required if any of these occur.

Meropenem is contraindicated in individuals with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics. Caution is also advised for patients with severe renal impairment who cannot be dose‑adjusted, and for those with a history of seizures unless benefits clearly outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT